Skip to main content
Top
Published in: Cancer Imaging 1/2016

Open Access 01-12-2016 | Research article

C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trial

Authors: Roland Syha, Sergios Gatidis, Gerd Grözinger, Ulrich Grosse, Michael Maurer, Lars Zender, Marius Horger, Konstantin Nikolaou, Dominik Ketelsen

Published in: Cancer Imaging | Issue 1/2016

Login to get access

Abstract

Background

This study aims to evaluate immediate changes in perfusion parameters in hepatocellular carcinoma (HCC) to transarterial chemoembolization (TACE) in C-arm computed tomography (CT) and volume perfusion CT (VPCT) and prediction of midterm tumor response.

Methods

Twenty-five patients (median age 66, range 61 to 75 years) with 62 HCC lesions undergoing TACE received immediate pre- and post-interventional assessment by C-arm CT and VPCT. Cross-sectional imaging was analyzed at baseline and approximately 12 weeks after TACE according to modified RECIST criteria. Outcome was defined as objective response (OR, > 30 % reduction of viable tumor) or non-OR. Perfusion parameters were evaluated in C-arm CT [parenchymal blood volume (PBV)] and VPCT [blood volume (BV) and blood flow (BF)]. Ratios of perfusion parameters before and after TACE within the tumor and the non-affected liver parenchyma were calculated.

Results

Correlation between tumor PBV and BV revealed a moderate correlation (rho = 0.45, p = 0.005). In non-affected liver parenchyma, a significant decrease in PBV was seen, compared to a significant increase in BF and BV. Perfusion ratios in HCC lesions were significantly (p < 0.05) increased in OR group compared to non-OR patients in C-arm CT and VPCT: PBV ratio (0.95 (0.06) to 0.67 (0.38), BV ratio 0.63 (0.34) to 0.15 (0.6), and BF ratio 0.6 (0.32) to 0.22 (0.51). Logistic regression including PBV and BF allowed prediction of OR (sensitivity 88 %/specificity of 83 %).

Conclusions

Perfusion parameters acquired by C-arm CT and VPCT cannot simply be substituted by each other, but show similar capability in prediction of midterm tumor response.
Literature
1.
go back to reference Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(03):329–38.CrossRefPubMed Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(03):329–38.CrossRefPubMed
2.
go back to reference Sommer CM, Stampfl U, Kauczor HU, Pereira PL. National S3 guidelines on hepatocellular carcinoma. Radiologe. 2014;54(7):642–53.CrossRefPubMed Sommer CM, Stampfl U, Kauczor HU, Pereira PL. National S3 guidelines on hepatocellular carcinoma. Radiologe. 2014;54(7):642–53.CrossRefPubMed
3.
go back to reference Vogl TJ, Lammer J, Lencioni R, et al. Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial. Am J Roentgenol. 2011;197(4):W562–70.CrossRef Vogl TJ, Lammer J, Lencioni R, et al. Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial. Am J Roentgenol. 2011;197(4):W562–70.CrossRef
4.
go back to reference Basile A, Carrafiello G, Ierardi A, Tsetis D, Brountzos E. Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc Intervent Radiol. 2012;35(4):765–74.CrossRefPubMed Basile A, Carrafiello G, Ierardi A, Tsetis D, Brountzos E. Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc Intervent Radiol. 2012;35(4):765–74.CrossRefPubMed
5.
go back to reference Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2009;33(1):41–52.CrossRefPubMedPubMedCentral Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2009;33(1):41–52.CrossRefPubMedPubMedCentral
7.
go back to reference Kakeda S, Korogi Y, Ohnari N, et al. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization. J Vasc Interv Radiol. 2007;18(12):1508–16.CrossRefPubMed Kakeda S, Korogi Y, Ohnari N, et al. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization. J Vasc Interv Radiol. 2007;18(12):1508–16.CrossRefPubMed
8.
go back to reference Miyayama S, Yamashiro M, Ikuno M, Okumura K, Yoshida M. Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software: technical success and short-term tumor response. Abdom Imaging. 2014;39(3):645–56.CrossRefPubMed Miyayama S, Yamashiro M, Ikuno M, Okumura K, Yoshida M. Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software: technical success and short-term tumor response. Abdom Imaging. 2014;39(3):645–56.CrossRefPubMed
9.
go back to reference Tognolini A, Louie JD, Hwang GL, Hofmann LV, Sze DY, Kothary N. Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization. J Vasc Interv Radiol. 2010;21(3):339–47.CrossRefPubMed Tognolini A, Louie JD, Hwang GL, Hofmann LV, Sze DY, Kothary N. Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization. J Vasc Interv Radiol. 2010;21(3):339–47.CrossRefPubMed
10.
go back to reference Syha R, Grözinger G, Grosse U, et al. C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads. Cancer Imaging. 2015;15:22.CrossRefPubMedPubMedCentral Syha R, Grözinger G, Grosse U, et al. C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads. Cancer Imaging. 2015;15:22.CrossRefPubMedPubMedCentral
11.
go back to reference Loffroy R, Lin M, Rao P, et al. Comparing the detectability of hepatocellular carcinoma by C-Arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging. Cardiovasc Intervent Radiol. 2012;35(1):97–104.CrossRefPubMed Loffroy R, Lin M, Rao P, et al. Comparing the detectability of hepatocellular carcinoma by C-Arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging. Cardiovasc Intervent Radiol. 2012;35(1):97–104.CrossRefPubMed
12.
go back to reference Peynircioğlu B, Hızal M, Barbaros Çil B, et al. Quantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy: comparison with MDCT perfusion. Diagn Interv Radiol. 2015;21:71–7.CrossRefPubMed Peynircioğlu B, Hızal M, Barbaros Çil B, et al. Quantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy: comparison with MDCT perfusion. Diagn Interv Radiol. 2015;21:71–7.CrossRefPubMed
13.
go back to reference Syha R, Grözinger G, Grosse U, et al. Parenchymal blood volume assessed by C-Arm–based computed tomography in immediate posttreatment evaluation of drug-eluting bead transarterial chemoembolization in hepatocellular carcinoma. Invest Radiol. 2016;51(2):121–6.CrossRefPubMed Syha R, Grözinger G, Grosse U, et al. Parenchymal blood volume assessed by C-Arm–based computed tomography in immediate posttreatment evaluation of drug-eluting bead transarterial chemoembolization in hepatocellular carcinoma. Invest Radiol. 2016;51(2):121–6.CrossRefPubMed
14.
go back to reference Vogl T, Schaefer P, Lehnert T, et al. Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE). Eur Radiol. 2016;26(3):755-63. Vogl T, Schaefer P, Lehnert T, et al. Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE). Eur Radiol. 2016;26(3):755-63.
15.
go back to reference Zhuang Z-G, Zhang X-B, Han J-F, et al. Hepatic blood volume imaging with the use of flat-detector CT perfusion in the angiography suite: comparison with results of conventional multislice CT perfusion. J Vasc Interv Radiol. 2014;25(5):739–46.CrossRefPubMed Zhuang Z-G, Zhang X-B, Han J-F, et al. Hepatic blood volume imaging with the use of flat-detector CT perfusion in the angiography suite: comparison with results of conventional multislice CT perfusion. J Vasc Interv Radiol. 2014;25(5):739–46.CrossRefPubMed
16.
go back to reference Ippolito D, Bonaffini PA, Ratti L, et al. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor. World J Gastroenterol. 2010;16(47):5993–6000.PubMedPubMedCentral Ippolito D, Bonaffini PA, Ratti L, et al. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor. World J Gastroenterol. 2010;16(47):5993–6000.PubMedPubMedCentral
17.
go back to reference Ippolito D, Capraro C, Casiraghi A, Cestari C, Sironi S. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging. Eur Radiol. 2012;22(4):803–11.CrossRefPubMed Ippolito D, Capraro C, Casiraghi A, Cestari C, Sironi S. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging. Eur Radiol. 2012;22(4):803–11.CrossRefPubMed
18.
go back to reference Kaufmann S, Schulze M, Spira D, Horger M. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report. Acta Radiol. 2015. doi:10.1177/0284185114566442. Kaufmann S, Schulze M, Spira D, Horger M. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report. Acta Radiol. 2015. doi:10.​1177/​0284185114566442​.
19.
go back to reference Grözinger G, Grözinger A, Horger M. The role of volume perfusion CT in the diagnosis of pathologies of the pancreas. Röfo. 2014;186(12):1082–93.PubMed Grözinger G, Grözinger A, Horger M. The role of volume perfusion CT in the diagnosis of pathologies of the pancreas. Röfo. 2014;186(12):1082–93.PubMed
20.
go back to reference Ketelsen D, Horger M, Buchgeister M, et al. Estimation of radiation exposure of 128-slice 4D-perfusion CT for the assessment of tumor vascularity. Korean J Radiol. 2010;11(5):547–52.CrossRefPubMedPubMedCentral Ketelsen D, Horger M, Buchgeister M, et al. Estimation of radiation exposure of 128-slice 4D-perfusion CT for the assessment of tumor vascularity. Korean J Radiol. 2010;11(5):547–52.CrossRefPubMedPubMedCentral
21.
go back to reference Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(01):052–60.CrossRef Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(01):052–60.CrossRef
22.
go back to reference Frampas E, Lassau N, Zappa M, Vullierme M-P, Koscielny S, Vilgrain V. Advanced hepatocellular carcinoma: early evaluation of response to targeted therapy and prognostic value of perfusion CT and dynamic contrast enhanced-ultrasound. Preliminary results. Eur J Radiol. 2013;82(5):e205–11.CrossRefPubMed Frampas E, Lassau N, Zappa M, Vullierme M-P, Koscielny S, Vilgrain V. Advanced hepatocellular carcinoma: early evaluation of response to targeted therapy and prognostic value of perfusion CT and dynamic contrast enhanced-ultrasound. Preliminary results. Eur J Radiol. 2013;82(5):e205–11.CrossRefPubMed
23.
go back to reference Chen X, Xiao E, Shu D, et al. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging. Eur J Gastroenterol Hepatol. 2014;26(1):109–13.CrossRefPubMed Chen X, Xiao E, Shu D, et al. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging. Eur J Gastroenterol Hepatol. 2014;26(1):109–13.CrossRefPubMed
24.
go back to reference Hayano K, Desai GS, Kambadakone AR, Fuentes JM, Tanabe KK, Sahani DV. Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion. Cancer Imaging. 2013;13(4):512–9.CrossRefPubMedPubMedCentral Hayano K, Desai GS, Kambadakone AR, Fuentes JM, Tanabe KK, Sahani DV. Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion. Cancer Imaging. 2013;13(4):512–9.CrossRefPubMedPubMedCentral
25.
go back to reference Pinato DJ, Arizumi T, Allara E, Jang JW, Smirne C, Kim YW, et al. Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. Clin Gastroenterol Hepatol. 2015;13(6):1204-8. Pinato DJ, Arizumi T, Allara E, Jang JW, Smirne C, Kim YW, et al. Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. Clin Gastroenterol Hepatol. 2015;13(6):1204-8.
26.
go back to reference Syha R, Grünwald L, Horger T, et al. Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography. Eur Radiol. 2013;24(3):770–9.CrossRefPubMed Syha R, Grünwald L, Horger T, et al. Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography. Eur Radiol. 2013;24(3):770–9.CrossRefPubMed
Metadata
Title
C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trial
Authors
Roland Syha
Sergios Gatidis
Gerd Grözinger
Ulrich Grosse
Michael Maurer
Lars Zender
Marius Horger
Konstantin Nikolaou
Dominik Ketelsen
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Cancer Imaging / Issue 1/2016
Electronic ISSN: 1470-7330
DOI
https://doi.org/10.1186/s40644-016-0088-y

Other articles of this Issue 1/2016

Cancer Imaging 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine